首页> 外文OA文献 >Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation

【2h】

Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation

机译：异丁移植后依鲁替尼治疗复发性CLL：持续的疾病反应和有希望的供体免疫调节

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ryan Christine E.; Logan Aaron C.; Rezvani Andrew; Kamdar Manali; Nakasone Hideki; Sahaf Bita; Otani Joanne; Kong Katherine A.; Klinger Mark; Faham Malek; Coutre Steven; Miklos David B.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation [J] . Ryan Christine E., Logan Aaron C., Rezvani Andrew, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：异丁移植后依鲁替尼治疗复发性CLL：持续的疾病反应和有希望的供体免疫调节
2. Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation [J] . Quinquenel Anne, de Fontbrune Flore Sicre, Durot Eric, British Journal of Haematology . 2017,第6期

机译：对异构干细胞移植后复发CLL复发CLL的完全供体逆转
3. Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation [J] . Quinquenel Anne, de Fontbrune Flore Sicre, Durot Eric, British Journal of Haematology . 2017,第6期

机译：对异构干细胞移植后复发CLL的伊布洛替尼治疗的完全供体逆转的回收
4. Vasoactive Intestinal Polypeptide Induces Regulatory Dendritic Cells Thai Prevent Acute Graft Versus Host Disease and Leukemia Relapse after Bone Marrow Transplantation [C] . MARIO DELGADO, ALEJO CHORNY, DOINA GANEA, International Symposium on VIP, PACAP, and Related Peptides . 2006

机译：血管活性肠道多肽诱导调节性树突细胞泰国预防急性移植物与骨髓移植后宿主病和白血病复发
5. Symptoms, functional status, and altered immunity in survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). [D] . Mitchell, Sandra A. 2008

机译：慢性移植物抗宿主病（cGVHD）的同种异体造血干细胞移植的幸存者的症状，功能状态和免疫力改变。
6. NCI First International Workshop on the Biology Prevention and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation [O] . David L. Porter, Edwin P. Alyea, Joseph H. Antin, -1

机译：生物学造血干细胞移植后复发后复发后的生物学预防和治疗第一国际讲习班：异种造血干细胞移植后复发治疗委员会的报告
7. Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse [O] . M Hahn, S Böttcher, S Dietrich, 2015

机译：异种造血干细胞移植缺陷 - 风险CLL：解剖免疫调节症疾病的根除和治疗复发

Ibrutinib Treatment of Relapsed CLL Following Allogeneic Transplantation: Sustained Disease Response and Promising Donor Immune Modulation

著录项

引文网络

相似文献

相关主题

期刊订阅